tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports

Arbutus Biopharma (ABUS) Cash flow

1,272 Followers

Arbutus Biopharma Cash Flow

ABUS's free cash flow for Q4 2025 was $-4.68M. For the 2025 fiscal year, ABUS's free cash flow was decreased by $25.39M and operating cash flow was $-4.68M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -39.64M$ -64.85M$ -85.94M$ -35.36M$ -67.53M
Investing Cash Flow
$ 15.58M$ 22.95M$ 50.77M$ -74.94M$ -12.68M
Financing Cash Flow
$ 5.72M$ 52.00M$ 30.65M$ 31.81M$ 137.24M
End Cash Position
$ 18.01M$ 36.33M$ 26.29M$ 30.78M$ 109.28M
Free Cash Flow
$ -39.64M$ -65.03M$ -86.94M$ -35.87M$ -68.34M
Currency in USD

Arbutus Biopharma Cash Flow